Evidence map›Paper›PMID 42172238›Full record

ArticleACS chemical biology2026

A Cysteine-Dependent Peptide Cyclase with Broad Substrate Tolerance Enables Chemoenzymatic Synthesis of Macolacin Analogs.

Miyu Morohashi, Sho Konno, Koki Yamashita, Kyoga Kamijo, Akihiro Taguchi, Masaki Mishima, Atsuhiko Taniguchi, Yoshio Hayashi

Abstract read
In one paragraph

Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miyu MorohashiSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.
Sho KonnoSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.ORCID 0000-0002-5851-4130
Koki YamashitaSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.
Kyoga KamijoSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.
Akihiro TaguchiSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.
Masaki MishimaSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.ORCID 0000-0001-7626-7287
Atsuhiko TaniguchiSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.
Yoshio HayashiSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo192-0392, Japan.ORCID 0000-0002-7010-6914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thioesterase (TE) domains catalyze peptide release and macrocyclization during nonribosomal peptide biosynthesis, typically via catalytic serine. In contrast, MacB-TE from macolacin biosynthesis employs a rare cysteine nucleophile, raising questions regarding the catalytic requirements of cysteine-dependent peptide cyclases. Here, we report the biochemical and functional characterization of MacB-TE and demonstrate its efficiency, regioselectivity, and exclusive macrocyclization. Using a synthetic thioester substrate, MacB-TE converted >99% of the linear precursor into the cyclic product within minutes. Mutational analysis demonstrated that Cys89 is indispensable for ring formation, whereas His218 and Asp116 support an efficient turnover. Notably, a D116S variant retained substantial cyclization activity, uncovering an unexpected tolerance at the acidic position of the catalytic triad. Comprehensive substrate profiling showed that MacB-TE accommodated extensive side-chain variations and diverse N-terminal lipid groups. The enzyme efficiently macrocyclized all nine alanine-scan variants, with six positions supporting near-quantitative conversion and the remaining three producing more than 80% of the cyclic products. Likewise, lipid-modified substrates, including those with aliphatic and aromatic motifs, were quantitatively converted into their corresponding macrocycles, indicating that lipid variation had a negligible impact on catalysis. Collectively, these findings establish MacB-TE as a highly efficient and broadly tolerant macrocyclase, enabling the chemoenzymatic synthesis of macolacin analogs and expanding the mechanistic understanding of Cys-type TEs.

Indexed as

CysteinePeptide SynthasesCyclizationSubstrate SpecificityCysteinePeptide Synthases

Identifiers

PMID42172238
PMCPMC13288461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.